{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:25:11Z","timestamp":1795094711344,"version":"4.10.2"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"London Health Sciences Foundation","award":["N\/A; philanthropic donations"],"award-info":[{"award-number":["N\/A; philanthropic donations"]}]},{"DOI":"10.13039\/100012118","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","award":["Clinician Scientist Grant"],"award-info":[{"award-number":["Clinician Scientist Grant"]}],"id":[{"id":"10.13039\/100012118","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5977-6","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T06:02:58Z","timestamp":1566194578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":234,"title":["Stereotactic ablative radiotherapy for the comprehensive treatment of 4\u201310 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9542-0627","authenticated-orcid":false,"given":"David A.","family":"Palma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Harrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohann J. M.","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Famke","family":"Schneiders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis J. A.","family":"Haasbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George B.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Yaremko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn S.","family":"Bauman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belal","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Schellenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"Gaede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Laba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Mulroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sashendra","family":"Senthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Swaminath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben J.","family":"Slotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja D.","family":"de Gruijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Senan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,19]]},"reference":[{"issue":"1","key":"5977_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman S, Weichselbaum R. Oligometastases. J Clin Oncol. 1995;13(1):8\u201310.","journal-title":"J Clin Oncol"},{"key":"5977_CR2","doi-asserted-by":"crossref","unstructured":"Pastorino U, Buyse M, Friedel G, Ginsberg RJ, Girard P, Goldstraw P, Johnston M, McCormack P, Pass H, Putnam JB Jr on behalf of the International Registry of Lung Metastases. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg. 1997;113(1):37\u201349.","DOI":"10.1016\/S0022-5223(97)70397-0"},{"issue":"4","key":"5977_CR3","doi-asserted-by":"publisher","first-page":"e0195149","DOI":"10.1371\/journal.pone.0195149","volume":"13","author":"JC Hong","year":"2018","unstructured":"Hong JC, Ayala-Peacock DN, Lee J, Blackstock AW, Okunieff P, Sung MW, Weichselbaum RR, Kao J, Urbanic JJ, Milano MT, et al. Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: a multi-institutional pooled analysis. PLoS One. 2018;13(4):e0195149.","journal-title":"PLoS One"},{"issue":"5","key":"5977_CR4","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1440-1843.2010.01759.x","volume":"15","author":"J Primrose","year":"2010","unstructured":"Primrose J, Treasure T, Fiorentino F. Lung metastasectomy in colorectal cancer: is this surgery effective in prolonging life? Respirology. 2010;15(5):742\u20136.","journal-title":"Respirology"},{"key":"5977_CR5","doi-asserted-by":"crossref","unstructured":"Palma D, Salama S, Lo S, Senan S, Treasure T, Govinden R, Weichselbaum R. The oligometastatic state \u2013 separating truth from wishful thinking. Nat Rev Clin Oncol. 2014; Accepted in press.","DOI":"10.1038\/nrclinonc.2014.96"},{"issue":"1","key":"5977_CR6","doi-asserted-by":"publisher","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","volume":"4","author":"P Iyengar","year":"2018","unstructured":"Iyengar P, Wardak Z, Gerber DE, Tumati V, Ahn C, Hughes RS, Dowell JE, Cheedella N, Nedzi L, Westover KD, et al. Consolidative radiotherapy for limited metastatic non-small-cell lung Cancer: a phase 2 randomized clinical trial. JAMA Oncol. 2018;4(1):e173501.","journal-title":"JAMA Oncol"},{"issue":"12","key":"5977_CR7","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","volume":"17","author":"DR Gomez","year":"2016","unstructured":"Gomez DR, Blumenschein GR Jr, Lee JJ, Hernandez M, Ye R, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Gibbons DL, et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 2016;17(12):1672\u201382.","journal-title":"Lancet Oncol"},{"key":"5977_CR8","doi-asserted-by":"crossref","unstructured":"Ruers T, Van Coevorden F, Punt CJ, Pierie JE, Borel-Rinkes I, Ledermann JA, Poston G, Bechstein W, Lentz MA, Mauer M, et al. Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial. J Natl Cancer Inst. 2017;109(9):1\u201310.","DOI":"10.1093\/jnci\/djx015"},{"issue":"10","key":"5977_CR9","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1093\/annonc\/mds053","volume":"23","author":"T Ruers","year":"2012","unstructured":"Ruers T, Punt C, Van Coevorden F, Pierie JPEN, Borel-Rinkes I, Ledermann JA, Poston G, Bechstein W, Lentz MA, Mauer M, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC intergroup phase II study (EORTC 40004). Ann Oncol. 2012;23(10):2619\u201326.","journal-title":"Ann Oncol"},{"issue":"3","key":"5977_CR10","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ijrobp.2018.06.105","volume":"102","author":"DA Palma","year":"2018","unstructured":"Palma DA, Olson RA, Harrow S, Gaede S, Louie AV, Haasbeek C, Mulroy LA, Lock MI, Rodrigues G, Yaremko BP, et al. Stereotactic Ablative Radiation Therapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): Results of a Randomized Trial. Int J Radiat Oncol Biol Physics. 2018;102(3):S3\u20134.","journal-title":"Int J Radiat Oncol Biol Physics"},{"key":"5977_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/1471-2407-12-305","volume":"12","author":"DA Palma","year":"2012","unstructured":"Palma DA, Haasbeek CJ, Rodrigues GB, Dahele M, Lock M, Yaremko B, Olson R, Liu M, Panarotto J, Griffioen GH, et al. Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial. BMC Cancer. 2012;12:305.","journal-title":"BMC Cancer"},{"issue":"10185","key":"5977_CR12","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","volume":"393","author":"David A Palma","year":"2019","unstructured":"Palma DA, Olson RA, Harrow S, Gaede S, Louie AV, Haasbeek C, Mulroy LA, Lock MI, Rodrigues G, Yaremko BP, et al. Stereotactic ablative radiotherapy versus standard-of-care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomized, phase II, open-label trial. Lancet. 2019;393(10185):2051\u20138.","journal-title":"The Lancet"},{"key":"5977_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1748-717X-6-80","volume":"6","author":"P Cheruvu","year":"2011","unstructured":"Cheruvu P, Metcalfe SK, Metcalfe J, Chen Y, Okunieff P, Milano MT. Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer. Radiat Oncol. 2011;6:80.","journal-title":"Radiat Oncol"},{"issue":"2","key":"5977_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3171\/2013.4.JNS121751","volume":"119","author":"P Rava","year":"2013","unstructured":"Rava P, Leonard K, Sioshansi S, Curran B, Wazer DE, Cosgrove GR, Noren G, Hepel JT. Survival among patients with 10 or more brain metastases treated with stereotactic radiosurgery. J Neurosurg. 2013;119(2):457\u201362.","journal-title":"J Neurosurg"},{"issue":"1","key":"5977_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijrobp.2017.01.204","volume":"98","author":"TA Ritter","year":"2017","unstructured":"Ritter TA, Matuszak M, Chetty IJ, Mayo CS, Wu J, Iyengar P, Weldon M, Robinson C, Xiao Y, Timmerman RD. Application of Critical Volume-Dose Constraints for Stereotactic Body Radiation Therapy in NRG Radiation Therapy Trials. Int J Radiat Oncol Biol Physics. 2017;98(1):34\u20136.","journal-title":"Int J Radiat Oncol Biol Physics"},{"issue":"3","key":"5977_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.radonc.2017.07.028","volume":"125","author":"O Bohoudi","year":"2017","unstructured":"Bohoudi O, Bruynzeel AME, Senan S, Cuijpers JP, Slotman BJ, Lagerwaard FJ, Palacios MA. Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer. Radiother Oncol. 2017;125(3):439\u201344.","journal-title":"Radiother Oncol"},{"key":"5977_CR17","doi-asserted-by":"crossref","unstructured":"Palacios MA, Bohoudi O, Bruynzeel AME, van Sornsen-de Koste JR, Cobussen P, Slotman BJ, Lagerwaard FJ, Senan S. Role of daily plan adaptation in MR-guided stereotactic ablative radiotherapy for adrenal metastases. Int J Radiat Oncol Biol Phys. 2018;102(2):426\u201333.","DOI":"10.1016\/j.ijrobp.2018.06.002"},{"key":"5977_CR18","doi-asserted-by":"crossref","unstructured":"van S\u00f6rnsen de Koste JR, Palacios MA, Bruynzeel AME, Slotman BJ, Senan S, Lagerwaard FJ. MR-guided Gated Stereotactic Radiation Therapy Delivery for Lung, Adrenal, and Pancreatic Tumors: A Geometric Analysis. Int J Radiat Oncol Biol Physics. 2018;102(4):858\u201366..","DOI":"10.1016\/j.ijrobp.2018.05.048"},{"key":"5977_CR19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.lungcan.2018.07.002","volume":"123","author":"H Tekatli","year":"2018","unstructured":"Tekatli H, Spoelstra FOB, Palacios M, van Sornsen de Koste J, Slotman BJ, Senan S. Stereotactic ablative radiotherapy (SABR) for early-stage central lung tumors: new insights and approaches. Lung Cancer. 2018;123:142\u20138.","journal-title":"Lung Cancer"},{"issue":"23","key":"5977_CR20","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-15-0822","volume":"21","author":"DA Palma","year":"2015","unstructured":"Palma DA, Louie AV, Rodrigues GB. New strategies in stereotactic radiotherapy for Oligometastases. Clin Cancer Res. 2015;21(23):5198\u2013204.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"5977_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/PPO.0000000000000202","volume":"22","author":"RJ Correa","year":"2016","unstructured":"Correa RJ, Salama JK, Milano MT, Palma DA. Stereotactic body radiotherapy for Oligometastasis: opportunities for biology to guide clinical management. Cancer J. 2016;22(4):247\u201356.","journal-title":"Cancer J"},{"issue":"12","key":"5977_CR22","doi-asserted-by":"publisher","first-page":"e50141","DOI":"10.1371\/journal.pone.0050141","volume":"7","author":"YA Lussier","year":"2012","unstructured":"Lussier YA, Khodarev NN, Regan K, Corbin K, Li H, Ganai S, Khan SA, Gnerlich JL, Darga TE, Fan H, et al. Oligo- and polymetastatic progression in lung metastasis (es) patients is associated with specific microRNAs. PLoS One. 2012;7(12):e50141.","journal-title":"PLoS One"},{"issue":"12","key":"5977_CR23","doi-asserted-by":"publisher","first-page":"e28650","DOI":"10.1371\/journal.pone.0028650","volume":"6","author":"YA Lussier","year":"2011","unstructured":"Lussier YA, Xing HR, Salama JK, Khodarev NN, Huang Y, Zhang Q, Khan SA, Yang X, Hasselle MD, Darga TE, et al. MicroRNA expression characterizes oligometastasis (es). PLoS One. 2011;6(12):e28650.","journal-title":"PLoS One"},{"issue":"6","key":"5977_CR24","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.18632\/oncotarget.2920","volume":"6","author":"A Uppal","year":"2015","unstructured":"Uppal A, Wightman SC, Mallon S, Oshima G, Pitroda SP, Zhang Q, Huang X, Darga TE, Huang L, Andrade J, et al. 14q32-encoded microRNAs mediate an oligometastatic phenotype. Oncotarget. 2015;6(6):3540\u201352.","journal-title":"Oncotarget"},{"issue":"4","key":"5977_CR25","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168(4):670\u201391.","journal-title":"Cell"},{"issue":"5","key":"5977_CR26","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1158\/2159-8290.CD-15-1483","volume":"6","author":"C Alix-Panabieres","year":"2016","unstructured":"Alix-Panabieres C, Pantel K. Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy. Cancer Discov. 2016;6(5):479\u201391.","journal-title":"Cancer Discov"},{"issue":"9","key":"5977_CR27","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1164\/rccm.201610-2178LE","volume":"196","author":"PL de Goeje","year":"2017","unstructured":"de Goeje PL, Smit EF, Waasdorp C, Schram MTB, Kaijen-Lambers MEH, Bezemer K, de Mol M, Hartemink KJ, Nuyttens J, Maat A, et al. Stereotactic ablative radiotherapy induces peripheral T-cell activation in patients with early-stage lung Cancer. Am J Respir Crit Care Med. 2017;196(9):1224\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7655","key":"5977_CR28","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature22364","volume":"545","author":"C Abbosh","year":"2017","unstructured":"Abbosh C, Birkbak NJ, Wilson GA, Jamal-Hanjani M, Constantin T, Salari R, Le Quesne J, Moore DA, Veeriah S, Rosenthal R, et al. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature. 2017;545(7655):446\u201351.","journal-title":"Nature"},{"issue":"16","key":"5977_CR29","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1200\/JCO.2017.76.8671","volume":"36","author":"JD Merker","year":"2018","unstructured":"Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, Lindeman N, Lockwood CM, Rai AJ, Schilsky RL, et al. Circulating tumor DNA analysis in patients with Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. J Clin Oncol. 2018;36(16):1631\u201341.","journal-title":"J Clin Oncol"},{"issue":"3","key":"5977_CR30","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cell.2018.03.057","volume":"173","author":"S Turajlic","year":"2018","unstructured":"Turajlic S, Xu H, Litchfield K, Rowan A, Chambers T, Lopez JI, Nicol D, O'Brien T, Larkin J, Horswell S, et al. Tracking Cancer evolution reveals constrained routes to metastases: TRACERx renal. Cell. 2018;173(3):581\u201394 e512.","journal-title":"Cell"},{"issue":"22","key":"5977_CR31","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","volume":"376","author":"M Jamal-Hanjani","year":"2017","unstructured":"Jamal-Hanjani M, Wilson GA, McGranahan N, Birkbak NJ, Watkins TBK, Veeriah S, Shafi S, Johnson DH, Mitter R, Rosenthal R, et al. Tracking the evolution of non-small-cell lung Cancer. N Engl J Med. 2017;376(22):2109\u201321.","journal-title":"N Engl J Med"},{"issue":"suppl","key":"5977_CR32","doi-asserted-by":"publisher","first-page":"abstr 1019","DOI":"10.1200\/JCO.2018.36.15_suppl.1019","volume":"36","author":"A Davis","year":"2018","unstructured":"Davis A, et al. The impact of circulating tumor cells (CTCs) detection in metastatic breast cancer (MBC): Implications of \u201cindolent\u201d stage IV disease (Stage IVindolent). J Clin Oncol. 2018;36(suppl):abstr 1019.","journal-title":"J Clin Oncol"},{"issue":"2","key":"5977_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccell.2017.06.009","volume":"32","author":"A Lopez-Soto","year":"2017","unstructured":"Lopez-Soto A, Gonzalez S, Smyth MJ, Galluzzi L. Control of metastasis by NK cells. Cancer Cell. 2017;32(2):135\u201354.","journal-title":"Cancer Cell"},{"issue":"7636","key":"5977_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nature20792","volume":"541","author":"L van der Weyden","year":"2017","unstructured":"van der Weyden L, Arends MJ, Campbell AD, Bald T, Wardle-Jones H, Griggs N, Velasco-Herrera MD, Tuting T, Sansom OJ, Karp NA, et al. Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Nature. 2017;541(7636):233\u20136.","journal-title":"Nature"},{"issue":"6","key":"5977_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.trecan.2016.05.002","volume":"2","author":"S Demaria","year":"2016","unstructured":"Demaria S, Coleman CN, Formenti SC. Radiotherapy: changing the game in immunotherapy. Trends Cancer. 2016;2(6):286\u201394.","journal-title":"Trends Cancer"},{"issue":"5","key":"5977_CR36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrc.2018.6","volume":"18","author":"W Ngwa","year":"2018","unstructured":"Ngwa W, Irabor OC, Schoenfeld JD, Hesser J, Demaria S, Formenti SC. Using immunotherapy to boost the abscopal effect. Nat Rev Cancer. 2018;18(5):313\u201322.","journal-title":"Nat Rev Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5977-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5977-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5977-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T19:14:31Z","timestamp":1597691671000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5977-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,19]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5977"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5977-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,19]]},"assertion":[{"value":"2 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval has been obtained from the Ontario Cancer Research Ethics Board (#1697). Written consent to participate will be obtained from individual study participants and will include consent to undergo study interventions as well as biomarker assessment. Sample consent form is in Additional\u00a0file\u00a0\n                      \n                      . Consent will be obtained at individual participating institutions by study investigators or clinical trials staff members.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RO has received grant funding from Varian Medical Systems, unrelated to this research project. DS has received grant funding from Varian Medical Systems Inc, and honoraria from AstraZeneca, Bayer, and Merck, unrelated to this research project. AVL has received honoraria from Varian Medical Systems and AstraZeneca, unrelated to this research project. SSenan has received grant funding from ViewRay and Varian Medical Systems, and honoraria from AstraZeneca, Celgene, and MSD, unrelated to this research project. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"816"}}